The discrepancy between the therapeutic effects of the two mTOR inhibitors was further evident in the marked worsening of the infection caused by rapamycin monotherapy compared to an opposing trend toward reduced bacterial load observed with CC214-2 monotherapy in both mouse strains. The gene discussed is MTOR; the disease is infection.